FATE 8-K: SEC filing

Fate Therapeutics

Filed with the SEC on · accession 0001193125-26-448530

FATE filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -11.5% by the first close after the filing.

Summary of the filing

Fate Therapeutics issued a press release announcing its financial results for the quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.

Key details

RegistrantFate Therapeutics, Inc.
President and chief executive officerBahram Valamehr

How FATE stock reacted

Close before

$2.09

Nov 4, 2026

First close after

-11.48%

$1.85

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for FATE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for FATE?

Click here

Frequently asked questions

What did FATE file with the SEC on Nov 5, 2026?

FATE filed a 8-K (SEC filing). Fate Therapeutics issued a press release announcing its financial results for the quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did FATE stock react to this filing?

FATE closed at $2.09 before the filing and $1.85 on Nov 5, 2026 (-11.48%).

Other FATE SEC filings

Get alerts when FATE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days